RT Journal Article
SR Electronic
T1 Nasal microbiota exhibit neither reproducible nor orderly dynamics following rhinoviral infection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.11.20061911
DO 10.1101/2020.04.11.20061911
A1 Sai N. Nimmagadda
A1 Firas S. Midani
A1 Heather Durand
A1 Aspen T. Reese
A1 Caitlin C. Murdoch
A1 Bradley P. Nicholson
A1 Timothy Veldman
A1 Thomas W. Burke
A1 Aimee K. Zaas
A1 Christopher W. Woods
A1 Geoffrey S. Ginsburg
A1 Lawrence A. David
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.11.20061911.abstract
AB Background How human-associated microbial communities resist and respond to perturbations remains incompletely understood. Viral challenge provides one opportunity to test how human microbiota respond to disturbance.Methods Using an experimental human rhinovirus infection challenge model, we explored how viral infection may alter microbiota of the upper respiratory tract (URT). Healthy human volunteers were inoculated with HRV serotype 39. Samples were collected by lavage before and after inoculation from healthy (sham inoculated, n=7) and infected (n=15) individuals and subjected to 16S rRNA gene sequencing through amplification of the V4 hypervariable region.Results No evidence for differences in community alpha-diversity between cohorts was observed. The composition of microbiota of sham-treated and infected subjects did not appear distinguishable and no taxa were significantly associated with infection status. We did not observe support for a correlation between microbial dynamics and counts of specific monocytes. Subject identity was found to be the strongest determinant of community structure in our dataset.Conclusions Overall, our findings do not suggest a consistent nasopharyngeal microbiota response to rhinovirus challenge. We support the conclusion that this microbial community is individualized. Broadly, our findings contribute to our understanding of how and when immune responses to viruses affect bacterial communities in the URT.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Defense Advanced Research Projects Agency (DARPA) [N66001-09-C-2082] and the Alfred P. Sloan Foundation (research fellowship to L.A.D).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA portion of data is available in the linked supplementary information. All other data that supports the findings of this study are available from the corresponding author(s) upon reasonable request.